← All diseases
Cancer
Neuroendocrine tumors
Would you like to receive a message when there is new research about neuroendocrine tumors? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication is one sentence that explains what was studied — and you receive a message as soon as there is new research about neuroendocrine tumors. View what Premium costs.
Publications and studies (2753)
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A novel dibenzoylmethane derivative (IDPIP) impairs melanoma cell migration and selectively induces apoptosis in vitro. (2026/10/01) ♡
- Electrode material and electrical delivery mode shape the mechanisms and efficacy of electrochemical tumor ablation. (2026/10/01) ♡
- Two citrus polymethoxyflavones, nobiletin and sudachitin, suppress melanogenesis through distinct molecular mechanisms. (2026/09/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Clinical Reasoning: A 79-Year-Old Man With Subacute Onset Involuntary Facial Movements and Discoordination. (2026/09/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Combination Treatment Strategies With Peptide Receptor Radionuclide Therapy: The Current Status and Potential Future Applications in Theranostics of Neuroendocrine Tumors. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neoadjuvant Therapy for Melanoma. (2026/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Multiple endocrine neoplasia presenting initially as acute pulmonary thromboembolism: a case report]. (2026/08/12) ♡
- Second primary malignancies in neuroendocrine tumors: a single-center cohort study. (2026/08/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Composite pheochromocytoma with ganglioneuroblastoma in an adult: a case report and literature review]. (2026/08/11) ♡
- Epidemiology and Overall Survival of De Novo and Transformed Neuroendocrine Prostate Cancer: A Two-Nation Population-Based Study of 1,465 Patients from the United States and England. (2026/08/10) ♡
- Belzutifan, A Hypoxia-Inducible Factor 2-Alpha Inhibitor, for Patients with Advanced Pheochromocytoma and Paraganglioma. (2026/08/10) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Managing hematological toxicity in [¹⁷⁷Lu]Lu-DOTATATE for NET patients: a national survey from the French group of endocrine tumors (GTE) on the clinical need for harmonized monitoring strategies. (2026/08/10) ♡
- Socioeconomic factors associated with post-operative biochemical remission in acromegaly. (2026/08/10) ♡
- Dual‑targeted radioligand therapy with [(177)Lu]Lu‑DOTATATE plus [(177)Lu]Lu‑DOTA‑IBA for bone metastases from neuroendocrine neoplasms: a prospective pilot study. (2026/08/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Sweat gland carcinoma with neuroendocrine differentiation: a clinicopathological analysis of three cases]. (2026/08/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Clinicopathological analysis of pulmonary composite gangliocytoma/neuroma and neuroendocrine tumors]. (2026/08/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transradial Embolization Prior to Surgical Resection of a Cardiac Paraganglioma Presenting as an Acute Coronary Syndrome With Normal Coronaries. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pituitary neuroendocrine tumors: imaging features, clinical relevance, and a proposal for standardized MRI reporting. (2026/08/08) ♡
- Diagnostic contribution of contrast-enhanced ultrasound in a small pancreatic neuroendocrine tumor: a case report. (2026/08/08) ♡
- Swiss survey and national diagnostic reference levels for PET/CT examinations in adults. (2026/08/07) ♡
- Somatic Genetic Alterations in Pituitary Neuroendocrine Tumors. (2026/08/07) ♡
- Management of Aggressive PitNETs: Evidence Gaps, Molecular Clues, and a Roadmap for Clinical Trials. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hypothalamic syndrome and acquired hypothalamic obesity: from fragmented care to integrated multidisciplinary management. (2026/08/07) ♡
- Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases. (2026/08/07) ♡
- Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy. (2026/08/07) ♡
- Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy. (2026/08/07) ♡
- Refining Prognostic Stratification in Head and Neck Paragangliomas: Insights from a SEER-Based Population Study. (2026/08/07) ♡
- Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas. (2026/08/07) ♡
- Urethral Metastasis of Therapy-Induced Neuroendocrine Prostate Cancer Successfully Managed With Chemoradiotherapy: A Case Report. (2026/08/07) ♡
- Analysis of outcome in patients with different primary localisation of neuroendocrine tumors after PRRT. 10 years single institution experience. (2026/08/06) ♡
- Ersodetug for Refractory Hypoglycemia Due to Malignant Insulin-Secreting Tumors. (2026/08/06) ♡
- Perioperative Risks of Concurrent Pancreatic and Hepatic Resections for Neuroendocrine Tumors. (2026/08/06) ♡
- Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer. (2026/08/06) ♡
- Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid. (2026/08/06) ♡
- Hematologic Consequences of Radiopharmaceutical Therapy: From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms. (2026/08/06) ♡
- Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells. (2026/08/06) ♡
- Patient Survival and Its Relation to Tumor Absorbed Dose in [(177)Lu]Lu-DOTATATE Therapy of Neuroendocrine Tumors. (2026/08/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Imaging Findings of an Exophytic Urinary Bladder Paraganglioma Mimicking a Gynecological Mass: A Case Report. (2026/08/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Applications of FDG-PET Imaging in the Management of Patients with Hepatobiliary and Pancreatic Tumors. (2026/08/05) ♡
- Biomarkers of metastatic disease in pheochromocytoma and paraganglioma. (2026/08/05) ♡
- Multi-omics integration unravels four molecular subgroups of corticotroph pituitary neuroendocrine tumours with distinct clinicopathological features. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Concepts in Pituitary Pathology. (2026/08/04) ♡
- Cutaneous Manifestations of Carcinoid Tumor and Syndrome. (2026/08/04) ♡
- Invasiveness, SOX2 Expression, and Resection Outcomes in TF-Defined PitNETs After Extra-Pseudocapsular Resection. (2026/08/03) ♡
- STK11 c.1062 C > G germline variant in medullary thyroid carcinoma: implications for familial predisposition and genetic counseling. (2026/08/03) ♡
- A stress-adaptive lipid kinase axis defines metabolic vulnerabilities in neuroendocrine prostate cancer. (2026/08/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Modified endoscopic mucosal resection versus endoscopic submucosal dissection for rectal neuroendocrine tumors ≤10 mm: a systematic review and meta-analysis of randomized controlled trials. (2026/08/03) ♡
- Pancreato-duodenal cancers in Pakistan: Patterns of presentation, disease burden and outcomes at a tertiary cancer facility. (2026/08/03) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multifocal Giant Granular Cell Tumors of the Alimentary Canal With Concurrent Eosinophilic Gastrointestinal Disease. (2026/08/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.